Market Value969,614,000
Total Holdings66
File Date2022-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
HARP / Harpoon Therapeutics, Inc.
COGT / Cogent Biosciences, Inc.
JANX / Janux Therapeutics, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
TIL / Instil Bio, Inc.
KZR / Kezar Life Sciences, Inc.
ALT / Altimmune, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
LABP / Landos Biopharma, Inc.
FMTX / Forma Therapeutics Holdings Inc
VRDN / Viridian Therapeutics, Inc.
OMGA / Omega Therapeutics, Inc.
VERV / Verve Therapeutics, Inc.
IKNA / Ikena Oncology, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
VERA / Vera Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
GHRS / GH Research PLC
BCEL / Atreca, Inc.
VTYX / Ventyx Biosciences, Inc.
ATHA / Athira Pharma, Inc.
STTK / Shattuck Labs, Inc.
PASG / Passage Bio, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
PRLD / Prelude Therapeutics Incorporated
KYMR / Kymera Therapeutics, Inc.
FATE / Fate Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
ZGNX / Zogenix Inc
FOLD / Amicus Therapeutics, Inc.
CGEM / Cullinan Therapeutics, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
ARNA / Arena Pharmaceuticals Inc
GRPH / Graphite Bio, Inc.
SLGC / Standard BioTools Inc.
ARQT / Arcutis Biotherapeutics, Inc.
KNTE / Kinnate Biopharma Inc.
ELDN / Eledon Pharmaceuticals, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
PYXS / Pyxis Oncology, Inc.
TALS / Talaris Therapeutics Inc
IPSC / Century Therapeutics, Inc.
SPRB / Spruce Biosciences, Inc.
LIAN / LianBio - Depositary Receipt (Common Stock)
FULC / Fulcrum Therapeutics, Inc.
PMVP / PMV Pharmaceuticals, Inc.
PTGX / Protagonist Therapeutics, Inc.
MRNS / Marinus Pharmaceuticals, Inc.
DICE / DICE Therapeutics Inc
ADGI / Adagio Therapeutics Inc
SYBX / Synlogic, Inc.
ALGS / Aligos Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
ALPN / Alpine Immune Sciences, Inc.
RLMD / Relmada Therapeutics, Inc.
BMEA / Biomea Fusion, Inc.
RAIN / Rain Enhancement Technologies Holdco, Inc.
JNCE / Jounce Therapeutics Inc
NKTX / Nkarta, Inc.
EPIX / ESSA Pharma Inc.
GBT / Global Blood Therapeutics Inc.
WVE / Wave Life Sciences Ltd.
VTGN / Vistagen Therapeutics, Inc.
RPTX / Repare Therapeutics Inc.
KRTX / Karuna Therapeutics, Inc.
TYRA / Tyra Biosciences, Inc.
NGM / NGM Biopharmaceuticals, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
ISEE / IVERIC bio Inc
ALXO / ALX Oncology Holdings Inc.
KROS / Keros Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
DSGN / Design Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc.
OLMA / Olema Pharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
CYTK / Cytokinetics, Incorporated
NUVL / Nuvalent, Inc.
DYN / Dyne Therapeutics, Inc.